During the past decade, Dermatologisches Ambulatorium Hamburg-Alstertal conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatologisches Ambulatorium Hamburg-Alstertal" #1 collaborator was "Bioskin GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dermatologisches Ambulatorium Hamburg-Alstertal" are "Actinic Keratosis" (1 trials), "Actinic Keratosis (AK)" (1 trials), "Peripheral Vascular Disease" (1 trials), "Psoriasis" (1 trials) and "Raynaud's Disease" (1 trials). Many other conditions were trialed in "Dermatologisches Ambulatorium Hamburg-Alstertal" in a lesser frequency.

Most popular intervention types in "Dermatologisches Ambulatorium Hamburg-Alstertal" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Imiquimod Cream, 5%" (1 trials), "Ingenol Mebutate Gel, 0.015%" (1 trials), "MP1032" (1 trials), "PF-00489791" (1 trials) and "Photodynamic Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dermatologisches Ambulatorium Hamburg-Alstertal" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Dermatologisches Ambulatorium Hamburg-Alstertal". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Dermatologisches Ambulatorium Hamburg-Alstertal, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dermatologisches Ambulatorium Hamburg-Alstertal, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".